U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07431437) titled 'One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease' on Feb. 18.
Brief Summary: The purpose of this study is to evaluate the long-term safety and efficacy of GENOSS PCB by enrolling and tracking patients who underwent percutaneous transluminal angioplasty using GENOSS PCB in patients with femoropopliteal artery disease.
Study Start Date: June 17, 2025
Study Type: OBSERVATIONAL
Condition:
PTA (Percutaneous Transluminal Angioplasty)
Femoropopliteal Artery Disease
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Genoss Co., Ltd.
Published by HT Digital Content Services with permission from Healt...